CLIN CANCER RES 润色咨询

CLINICAL CANCER RESEARCH

出版年份:1995 年文章数:9146 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2018-03-22 120583eam68(暂无昵称)

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:好贵啊
    Standard Fees

    The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below.

    Cancer Discovery
    Publication fee: $2,500 for all article types
    Color fee: $450 per figure.

    Cancer Research, Clinical Cancer Research
    Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types)
    Color fee: $675 per figure.

    Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics
    Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types)
    Color fee: $625 per figure.

    Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research
    Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types)
    Color fee: $625 per figure.

    No fees will be charged for certain invited article types solicited directly by an editor.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2018-02-09 Dr. H

    实时if?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2018-01-10 ms8775166821456669

    文章从10几分外审修回拒稿下来的。所以接收很顺利。
    要求每个作者都要确认.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-12-29 yyllll

    这个杂志的版面费多少

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-12-08 ziecoe

    现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-12-04 小ren

    你又遇到过嘛wxsession269cd70b 2017-12-03 21:12:00 发表:
    你猜

    wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-12-03 wxsession269cd70b

    你猜小骞 2017-11-30 发表::
    研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?

    小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-12-01 小ren

    我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-11-30 小ren

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=554040, encodeId=513e55404004, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:好贵啊 <br> Standard Fees <br> <br> The standard fees charged for publication include a flat publication fee based on the journal and article type and an additional handling fee for each color figure. These fees are detailed below. <br> <br> Cancer Discovery <br> Publication fee: $2,500 for all article types <br> Color fee: $450 per figure. <br> <br> Cancer Research, Clinical Cancer Research <br> Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types) <br> Color fee: $675 per figure. <br> <br> Cancer Immunology Research, Molecular Cancer Research, Molecular Cancer Therapeutics <br> Publication fee: $1,200 for Research Articles and Reviews ($1,000 for all other article types) <br> Color fee: $625 per figure. <br> <br> Cancer Epidemiology, Biomarkers & Prevention, Cancer Prevention Research <br> Publication fee: $800 for Research Articles ($1000 for Reviews, $300 for Null Results in Brief and $650 for all other article types) <br> Color fee: $625 per figure. <br> <br> No fees will be charged for certain invited article types solicited directly by an editor., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Thu Mar 22 20:13:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552520, encodeId=4589552520ec, content=实时if?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Fri Feb 09 00:00:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=840380, encodeId=aa458403809d, content=文章从10几分外审修回拒稿下来的。所以接收很顺利。<br> 要求每个作者都要确认. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72925414015, createdName=ms8775166821456669, createdTime=Wed Jan 10 23:00:43 CST 2018, time=2018-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550458, encodeId=e7cd55045852, content=这个杂志的版面费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e7b2036216, createdName=yyllll, createdTime=Fri Dec 29 00:00:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549828, encodeId=529e54982809, content=现在这个杂志是不是投过去.主编都要审一次.然后提出大修意见.让你修了之后才送外审?修回送外审的几率有多大?修了之后一般外审专家还会提很多意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Fri Dec 08 09:00:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549714, encodeId=b491549e1439, content=你又遇到过嘛<span class="quote">wxsession269cd70b 2017-12-03 21:12:00 发表:<br>你猜</span>, beContent=wxsession269cd70b 2017-12-03 21:12:00 发表: 你猜, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Mon Dec 04 00:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549684, encodeId=9c82549684fa, content=你猜<span class="quote">小骞 2017-11-30 发表::<br>研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?</span>, beContent=小骞 2017-11-30 发表:: 研究方向:肿瘤生物学特性;; 接收率:约25% 审稿时间:约1个月 我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/t8HGwnUZ17icT6pQfT7ibLIC3aSWgs0DzhbTMWQmtQz1G9a9QPoDkibUY01cL5eJErbArS1eoOEiaedTKeRcQUeqxw/0, createdBy=7b0e2214224, createdName=wxsession269cd70b, createdTime=Sun Dec 03 21:12:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549627, encodeId=38c054962e94, content=我想问下最近大家投这个杂志有没有主编内审后.先修回补实验.再送外审的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Fri Dec 01 11:26:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549589, encodeId=ae9354958976, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:我想问问大家我的文章2周后意见修回,没有送外审,直接编辑要我大修,大家有没有遇到同样的情况?这是这个杂志的必须经过的步骤才能外审吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=593c2104325, createdName=小ren, createdTime=Thu Nov 30 05:44:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549365, encodeId=829f549365d4, content=崩溃,原来Under review并不代表送审 <br> <br> Stage Start Date <br> Decision Sent to Author 2017-11-20 10:14:22 <br> Under Review 2017-11-15 07:16:05 <br> Under Editorial Consideration 2017-11-13 09:19:31 <br> Initial QC 2017-11-13 05:34:41 <br> Manuscript Submission 2017-11-12 21:56:06 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3de1611793, createdName=misang, createdTime=Tue Nov 21 08:48:00 CST 2017, time=2017-11-21, status=1, ipAttribution=)]
    2017-11-21 misang

    崩溃,原来Under review并不代表送审

    Stage Start Date
    Decision Sent to Author 2017-11-20 10:14:22
    Under Review 2017-11-15 07:16:05
    Under Editorial Consideration 2017-11-13 09:19:31
    Initial QC 2017-11-13 05:34:41
    Manuscript Submission 2017-11-12 21:56:06

    0

共255条页码: 8/26页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分